AI assistant
Sending…
Salarius Pharmaceuticals, Inc. — Director's Dealing 2024
Feb 22, 2024
35494_dirs_2024-02-22_0cd42b88-b992-42d6-9947-05d9b5d74afb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Salarius Pharmaceuticals, Inc. (SLRX)
CIK: 0001615219
Period of Report: 2024-02-20
Reporting Person: Lammers Paul (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-20 | Stock Option (right to buy) | $0.5711 | A | 20500 | Acquired | 2034-02-19 | Common Stock (20500) | Direct |
More from Salarius Pharmaceuticals, Inc.
Regulatory Filings
2026
May 19
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Apr 2
Declaration of Voting Results & Voting Rights Announcements
2026
Feb 25
Major Shareholding Notification
2026
Feb 17
Proxy Solicitation & Information Statement
2026
Jan 9
Regulatory Filings
2026
Jan 8
Delisting Announcement
2026
Jan 2
Director's Dealing
2026
Jan 2